Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 589-600 of 1,909
Drug study icon
TerminatedNCT02909504

Gao NARASD Lithium Study

This summary needs review. Please check the official study record and contact the research team for details.

In Cleveland
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugA study involving a medication or substance.From 18 Years to 70 Years
Countries
United States
Sponsor
Keming Gao
Condition
Bipolarity
Drug study icon
CompletedNCT00460226

Lamictal Bipolar Observational Study

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugOver 18 Years
Countries
Sponsor
GlaxoSmithKline
Condition
Bipolarity
Drug study icon
CompletedNCT06005155

Lithium Versus Anticonvulsants and the Risk of Physical Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Copenhagen
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 5 Years to 100 Years
Countries
Denmark
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Condition
Bipolarity
Behavioral study icon
CompletedNCT03160664

Magnetic Seizure Therapy for Bipolar Mania

This summary needs review. Please check the official study record and contact the research team for details.

In Shanghai
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioralFrom 18 Years to 55 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Bipolarity
Behavioral study icon
CompletedNCT03358238

Modeling Mood Course to Detect Markers of Effective Adaptive Interventions

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Ann Arbor
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioralOver 18 Years
Countries
United States
Sponsor
University of Wisconsin, Madison
Condition
Bipolarity
Other study type icon
CompletedNCT00586222

Omega 3 Fatty Acid study

This summary needs review. Please check the official study record and contact the research team for details.

In Rochester
Why is this study shown?

This study is directly about Bipolarity.

BipolarityOtherFrom 12 Years to 18 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Bipolarity
Drug study icon
TerminatedNCT01113541

One-Year study of Oral Ziprasidone in Bipolar people with Metabolic Syndrome

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Calgary
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT00330486

Open Label study of Acamprosate in Bipolar Alcoholics

This summary needs review. Please check the official study record and contact the research team for details.

In Charleston
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Bipolarity
Drug study icon
CompletedNCT00141505

PK Effects of Bifeprunox & Valproate in Bipolar I

This summary needs review. Please check the official study record and contact the research team for details.

In Atlanta
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Solvay Pharmaceuticals
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.